Career for Medical Representative, Area Business Manager @ Synokem Pharmaceuticals
Synokem is a professionally managed fast growing Pharmaceuticlas Company having three decades of manufacture and Marketing Experience. We are based in the National Capital and are having a new ultra modern plant at haridwar in the state of Uttarakhand which falls under the (100% Excise free and 1% CST Zone). The Company has been accredited with WHO-GMP Certification. It is a ISO- 9001:2008 Certified unit with total quality managemant and Inhouse testing laboratory. Our success is the result of focusing on our clients' top priorities such as QUALITY PRODUCTS, ON-TIME DELIVERY, COMPENTETITIVE RATES and UNPARALLELED Responsiveness.
Synokem Manufactures more than 500 pharmaceutical formulations products in the form of Tablets, capsules, Liquid orals & Sustained Release Preparations.
Post: Medical Representative, Area Business Manager

DelCure LifeSciences Ltd. (DLL) is a full scale pharmaceutical company with an aim to bring differentiated high quality products through international collaboration with innovator companies from the USA, Switzerland, and European countries. High quality products are assured from our manufacturing partner of high repute.
Health Management and Research Institute is a registered non-profit organization based in Hyderabad, Andhra Pradesh. HMRI is supported by Piramal Foundation. and works towards making healthcare accessible, affordable and available to all segments of the population, especially those most vulnerable. In order to achieve this goal, HMRI leverages cutting edge information and communication technologies to cut costs without compromising quality as well as public-private partnerships to scale its solutions throughout India and beyond.
The Drugs and Cosmetics Rules, 1945 (D&C rules) were amended vide Drugs and Cosmetics (Fourth Amendment) Rules, 2013 published under Gazette notification G.S.R. 588(E) dated 30.08.2013 regarding the inclusion of Schedule H1 under the D&C rules containing certain antibiotics, anti-TB drugs and habit forming drugs. The notification states that these rules will come into force after six months of their publication in the official Gazette i.e. from 1st March, 2014
